RFK Jr. on Ozempic, Eli Lilly's next test, and Elon Musk gets on the bandwagon: Pharma news roundup - Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars - Scoop: Trump, RFK Jr. dine with Pfizer and Lilly execs - Medicaid dominates coverage of Novo, Lilly weight-loss drugs - U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug - Lilly Fires Warning Shot at Copycat Drug Makers After Shortage - Lilly slashes prices on lowest doses of weight loss drug Zepbound - Lilly's weight-loss drug cuts diabetes risk by 94% in three-year trial, company says - Lilly Gains in Obesity Race With Novo as Supplies Expand - FDA approves Eli Lilly Alzheimer's drug, expanding treatment options in the U.S.